Statins, long hailed for lowering cholesterol, might offer an unexpected benefit beyond heart health—they could help slow ...

A new study suggests that a treatment for Alzheimer's, the most common type of dementia, can also treat the second most common type – dementia with Lewy bodies (DLB). The treatment is a ...

The first new guidelines for diagnosing Alzheimer's disease in nearly 30 years establish earlier stages of the mind-robbing disease, ...

The benefit-risk balance is tipping more in favor of Eli Lilly’s Kisunla in early Alzheimer’s disease as the FDA ...

Alzheimer’s disease treatments aim to address symptoms such as memory loss, cognitive decline, difficulty with daily activities, and behavioral changes. While there is no current cure for ...

Narrowing the divide in Alzheimer’s treatment by collecting more and better data is crucial to avoid inconsistent practices and care for people with Alzheimer's.

There’s no cure for Alzheimer’s disease, ... Healthline has strict sourcing guidelines and relies on peer-reviewed studies, ... Anti-amyloid treatment in asymptomatic Alzheimer’s disease (A4).

An experimental Alzheimer's treatment shows promise in delaying symptoms, ... WHILE ANNE IS USING THE BOOK AS A GUIDELINE, THE BOOK’S TITLE, THE END OF ALZHEIMER’S AND ITS PHILOSOPHY, ...

Lilly's Kisunla gets FDA approval for a new dosing schedule that significantly lowers ARIA-E risk while maintaining amyloid ...

Revised guidelines for amyloid and tau positron emission tomography for Alzheimer’s disease and dementia state these tests should only be ordered if the results will directly impact care, like ...

Statins, long hailed for lowering cholesterol, might offer an unexpected benefit beyond heart health—they could help slow Alzheimer’s disease. A new study suggests that these common ...